HCV NS3 protease inhibitors

Details for Australian Patent Application No. 2009335904 (hide)

Owner Gilead Sciences, Inc.

Inventors Link, John O.; Vivian, Randall W.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009335904

PCT Pub. Number WO2010/080389

Priority 61/139,434 19.12.08 US

Filing date 15 December 2009

Wipo publication date 15 July 2010

International Classifications

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 31/06 (2006.01)

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

4 August 2011 PCT application entered the National Phase

  PCT publication WO2010/080389 Priority application(s): WO2010/080389

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009335924-Hemifumarate salt of 1- [4- [1- ( 4 - cyclohexyl-3 -trifluoromethyl-benzyloxyimino ) -ethyl] -2 - ethyl-benzyl] -a zetidine-3-carboxylic acid

2009335903-Reducing byproduction of malonates in a fermentation process